GeneDx Holdings Cash Flow Statement 2019-2024 | WGS

Fifteen years of historical annual cash flow statements for GeneDx Holdings (WGS).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-175.77$-548.98$-245.39$-241.34$-29.70
$33.73$59.31$21.87$11.73$6.41
$0.13$137$25.01$123$5.31
$33.86$196$46.88$134$11.71
$10.26$5.53$5.54$-10.61$-4.57
$0.98$2.35$-10.62$-8.98$-7.97
$0$0$0$0$0
$-2.53$-8.46$-12.75$18.63$-1.05
$-38.24$33.88$8.08$13.85$-0.74
$-180.15$-319.16$-190.43$-93.13$-18.73
$-1.68$-14.32$-20.79$-31.97$-15.46
$0$0$0$0$0
$-12.14$-127.00$0$0$0
$-29.91$0$0$0$0
$0$0$0$0$0
$-29.91$0$0$0$0
$0$0$0$0$0
$-43.73$-141.33$-20.79$-31.97$-15.46
$42.95$-3.29$-13.47$11.73$-1.71
$0$0$0$0$0
$42.95$-3.29$-13.47$11.73$-1.71
$143$201$559$0$0
$143$201$559$117$119
$0$0$0$0$0
$0$0$-52.30$0$30.90
$186$197$494$129$148
$-37.64$-263.17$283$3.95$114
$-0.33$41.98$219$120$5.48
$0$0$0$0$0